One Patient One Cure is a U.S.-based nonprofit with a global mission to transform healthcare through cutting-edge science and technology. We advance research, accelerate drug discovery, and pioneer truly personalized medicine by integrating artificial intelligence with deep biological insights.
The ribbons represent our commitment to moving beyond genetics—unlocking the power of transcriptomics, proteomics, and more to fuel the next generation of precision medicine.
The heart stands for our passion and promise: to make these life-changing innovations accessible to everyone, everywhere.
Revolutionizing healthcare with cutting‑edge technology to deliver affordable precision medicine to everyone, everywhere.
Breaking Financial Barriers in Rare Disease Research
By harnessing vast public datasets and state‑of‑the‑art bioinformatics, our AI platform shatters the funding ceiling that has long stalled rare disease breakthroughs. We’re igniting hope for patients who’ve been overlooked by traditional, cost‑heavy drug discovery—delivering life‑changing insights without the hefty price tag.
Bringing True Personalized Healthcare to Life
We’re ending the era of “one‑size‑fits‑all” medicine. By integrating multi‑omics data with intelligent machine learning, our approach tailors treatments to each individual—turning the promise of personalized care into everyday reality, one patient, one cure at a time.
Next‑Generation, Unbiased Precision Medicine
Going beyond genetics alone, our AI‑driven model weaves together layers of biological data—RNA, proteins, and more—to craft treatments that reflect the full complexity of each patient. This is precision medicine reimagined: truly personalized, deeply informed, and free from the blind spots of conventional approaches.
Meet our first model: CureCancer
CureCancer is One Patient One Cure’s first AI-powered predictor model, set to launch in 2026.
Trained on matched scientific datasets—including transcriptomes, proteomes, and drug sensitivities from thousands of cancer models—it has developed a remarkable ability to predict the most effective treatment for each cancer patient based on their unique biological features.
If you’re interested in being among the first to benefit from it, share your story with us and secure your spot on the waiting list now.
By 2030, we aim to make CureCancer accessible worldwide at an average cost of no more than $1,000—from biopsy to drug prediction.
We are also developing advanced ex vivo drug testing methods that allow for rapid testing of the top predicted drugs using a patient’s own cells, ensuring 100% certainty of treatment effectiveness.
Join our team or support our mission to help shape the future of precision cancer treatment.